Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-25 @ 1:52 PM
NCT ID: NCT00749892
Description: Toxicities were measured at weekly visit while on therapy using the NCI CTCAE v3.0.
Frequency Threshold: 5
Time Frame: Evaluated for 2 months once drug therapy started.
Study: NCT00749892
Study Brief: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pre-surgical Erlotinib Treatment Erlotinib 150 mg by mouth daily for 3 weeks followed by cystectomy within 24 hours of the last dose. 0 None 5 31 19 31 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders NCI CTCAE V3.0 View
Decreased Neutrophils/Grabulocytes SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders NCI CTCAE V3.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders NCI CTCAE V3.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders NCI CTCAE V3.0 View
Infection-wound SYSTEMATIC_ASSESSMENT Infections and infestations NCI CTCAE V3.0 View
Decreased Leukocytes (Total WBD) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders NCI CTCAE V3.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders NCI CTCAE V3.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTCAE V3.0 View
Lymphopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders NCI CTCAE V3.0 View
Decreased Neutrophils/Grabulocytes SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders NCI CTCAE V3.0 View